Biolevate raises €30M Series A and opens Boston office for its life sciences AI
- What changed
- Biolevate raised €30M in Series A funding and opened a Boston office for its life sciences AI automation products.
- Why you should care
- Venture funding supports continued scaling and market expansion of life sciences AI tools.
- Your move
- Watch. Monitor adoption and expansion milestones following the funding round.
- Evidence
- ConfirmedThe Next Web ↗
- What to watch next
- Subsequent customer announcements or product updates from the expanded Boston office.
- Event
- business move
- Event date
- Sep 22, 2026
- Relevant to
- General AI readers